Skip to main content
Fig. 8 | Nano Convergence

Fig. 8

From: Transmissible H-aggregated NIR-II fluorophore to the tumor cell membrane for enhanced PTT and synergistic therapy of cancer

Fig. 8

In vivo synergistic therapy of RRIALP-C4. a Tumor weight of different treatment groups after 15 days of treatment. b Tumor volume change curves of different treatment groups during the monitoring period. c Bodyweight change curves of mice in different treatment groups. d Images of tumor changes with the synergistic treatment of RRIAP-C4 for 15 days. e Tumor sizes of different treatment groups after 15 days of treatment. f H&E and Tunel staining of tumor sections after 15 days of treatment

Back to article page